The FDA changed the HRT warning label — what it means for you.

For more than twenty years, every package of menopause hormone therapy carried the FDA's most severe caution: a boxed warning. It shaped how prescribers talked about hormones, how pharmacists dispensed them, and how a generation of women felt about a treatment many of them needed.

In November 2025, the FDA removed that boxed warning from systemic estrogen-containing menopause hormone therapy.

Where the warning came from

The boxed warning was a legacy of the Women's Health Initiative — the large 2002 trial whose early, headline interpretation linked hormone therapy to increased cardiovascular and breast cancer risk. What got lost in that headline: the average WHI participant was in her 60s, often more than a decade past menopause. The findings were applied to all women, of all ages, on all formulations.

What changed — and why

Two decades of re-analysis and newer data pointed consistently at a different picture, often called the timing hypothesis: for symptomatic women who begin hormone therapy within roughly ten years of menopause onset (or before age 60), the benefit-risk balance looks meaningfully more favorable than the blanket warning implied. The FDA's label change reflects that accumulated evidence — moving hormone therapy from "warn everyone identically" to "assess the individual."

What didn't change

• The endometrial protection rule. The warning about endometrial cancer remains on estrogen-alone products — because unopposed estrogen in a woman with a uterus genuinely does raise that risk. If you have a uterus, progesterone stays part of the plan.
• Individual assessment. Hormone therapy still isn't right for everyone. Personal and family history, timing, symptoms, and preferences all shape the decision.
• The need for follow-up. Therapy is started, adjusted, and monitored — not set and forgotten.

What it means for you

If you were told "no" years ago — or told yourself no because of what you'd heard — the conversation is open again. The question isn't "is HRT safe?" as a yes/no for all women. It's "what does the evidence say for a woman with my history, at my stage?" That's a question worth asking with a clinician who works in this territory every day.